Zydus Gets US FDA Nod to Market Antibiotic Drug Azithromycin
Zydus Lifesciences, the Indian pharma company has received FDA approval to produce and market antibiotic Azithromycin. The antibiotic is used to treat bacterial infections.
Everything You Need to Know About Azithromycin Antibiotic
"Zydus Lifesciences Limited (including its subsidiaries/affiliates) has received final approval from the US Food and Drug Administration (FDA) to manufacture and market Azithromycin tablets USP, 500 mg," the company said in a statement.
The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad, the company said.
‘Azithromycin antibiotic is used for bacterial infections treatment such as bronchitis, pneumonia, sexually transmitted diseases (STD), infections of the ears, lungs, sinuses, skin, throat, and reproductive organs.’
In the US, Azithromycin tablets USP, 500 mg had annual sales of $20 million, it said citing IQVIA MAT February 2023 data.
Source: IANS